Breast Cancer Breakthroughs Episode 13: Unlocking the Potential of Immunotherapy in TNBC скачать в хорошем качестве

Breast Cancer Breakthroughs Episode 13: Unlocking the Potential of Immunotherapy in TNBC

Immunotherapy harnesses your body’s own immune system to fight tumors and has played an important role in treating triple negative breast cancer (TNBC) since it was first introduced in 2020. But researchers wonder, can immunotherapy be improved? In this episode of Breast Cancer Breakthroughs, we speak with former Komen Scholar and medical oncologist Dr. Melinda Telli to explain how researchers are unlocking the potential of immunotherapy in TNBC. We also speak with medical oncologist Dr. Stephanie Graff to discuss the impact of what some of this groundbreaking research will have on people with TNBC. Kelsey Hampton, PhD, is Director, Mission Communications & Education at Susan G. Komen Dr. Melinda Telli is a medical oncologist at Stanford University Dr. Stephanie Graff is a medical oncologist at Brown University Sign up for reminders about future episodes of Breast Cancer Breakthroughs here: https://www.komen.org/about-komen/our... Link to Survey: https://susangkomen.iad1.qualtrics.co... Clinical Trial Finder: https://www.breastcancertrials.org/BC... Videos: Under the Microscope: Immunotherapy: Unmasking Cancer Cells:    • Immunotherapy: Unmasking Cancer Cells   Under the Microscope: A Quick Guide to Triple Negative Breast Cancer:    • A Quick Guide to Triple Negative Breast Ca...   Under the Microscope: TROP2: A Promising Drug Target:    • TROP2: A Promising Breast Cancer Drug Target   Breast Cancer Breakthroughs Episode 4: Unmet Needs in TNBC: https://youtube.com/live/NYyqG3UO6FA?... Resources: Triple negative breast cancer: https://www.komen.org/breast-cancer/d... Immunotherapy: https://www.komen.org/breast-cancer/t... Immunotherapy for metastatic breast cancer: https://www.komen.org/breast-cancer/m... TROP2 antibody drug conjugates for metastatic breast cancer: https://www.komen.org/breast-cancer/m... Clinical Trials Mentioned in Episode: BEGONIA (active, not recruiting): https://www.clinicaltrials.gov/study/... TROPION-Breast01 (active, not recruiting): https://clinicaltrials.gov/study/NCT0... TROPION-Breast02 (active, not recruiting): https://clinicaltrials.gov/study/NCT0... TROPION-Breast03 (active, not recruiting): https://clinicaltrials.gov/study/NCT0... TROPION-Breast04 (recruiting): https://clinicaltrials.gov/study/NCT0... TROPION-Breast05 (recruiting): https://clinicaltrials.gov/study/NCT0... ASCENT-03 (recruiting): https://clinicaltrials.gov/study/NCT0... ASCENT-04 (active, not recruiting): https://clinicaltrials.gov/study/NCT0... ASCENT-05 (recruiting): https://www.clinicaltrials.gov/study/... 00:00 Introduction 01:19 What is Immunotherapy 06:42 Progress for immunotherapy in TNBC 11:50 Combining immunotherapy with antibody drug conjugates 20:57 Conclusion